Macular degeneration and diabetes: Links and more
Medical News Today· 7 days agoMacular degeneration describes a loss of central vision due to damage to part of the retina. People with diabetes might have an increased risk of...
Gene therapy for macular degeneration: Uses and more
Medical News Today· 7 days agoSeveral gene therapies are undergoing clinical trials. In this article, learn more about gene therapy and its potential role in treating macular ...
Genentech BrandVoice: Preserving Sight Through Innovation
Forbes· 1 day agoAntibodies play a crucial role in the immune system, helping to fight off infections and other...
OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of...
Morningstar· 5 days agoThe objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
Critical Analysis: 4D Molecular Therapeutics (FDMT) versus The Competition
ETF DAILY NEWS· 12 hours ago4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) is one of 263 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its ...
Eye expert releases song about the importance of eye examinations
Digital Journal· 3 days agoEye exams are extremely important as people age to prevent blindness from cataracts, glaucoma, retinopathy and macular degeneration, and to reduce eye strain ...
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
Zacks via Yahoo Finance· 6 days agoA potential approval for the 16-week dosing regimen would provide a longer treatment interval and...
NVISION® Eye Centers Continues National Expansion
WCMH Columbus· 6 days agoALISO VIEJO, Calif. , June 30, 2022 /PRNewswire/ -- NVISION® Eye Centers is pleased to announce the addition of two retina practices to the NVISION family – Salt Lake Retina in Salt Lake City ...
Genentech BrandVoice: She Was Losing Her Vision — Until Science Saved Her Sight
Forbes· 2 days agoSue is no stranger to vision problems. As she witnessed her mother’s vanishing vision, Sue couldn’t...
Amgen's Beating the Market -- Here's Why It's a Buy Now | The Motley Fool
The Motley Fool· 5 days agoAmgen (AMGN 0.93%) is the world's largest biotechnology company by revenue, focusing on using living...